Meilan Liu

2.1k total citations
46 papers, 1.6k citations indexed

About

Meilan Liu is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Meilan Liu has authored 46 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 17 papers in Oncology and 11 papers in Cancer Research. Recurrent topics in Meilan Liu's work include PARP inhibition in cancer therapy (7 papers), Cell death mechanisms and regulation (6 papers) and Cancer-related Molecular Pathways (6 papers). Meilan Liu is often cited by papers focused on PARP inhibition in cancer therapy (7 papers), Cell death mechanisms and regulation (6 papers) and Cancer-related Molecular Pathways (6 papers). Meilan Liu collaborates with scholars based in United States, China and Canada. Meilan Liu's co-authors include Felix Y. Feng, Corey Speers, Lori J. Pierce, Theodore S. Lawrence, Liang Xu, Zaneta Nikolovska‐Coleska, Yao Dai, Wenhua Tang, Harry Bartelink and Sumin Han and has published in prestigious journals such as Journal of the American Chemical Society, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Meilan Liu

41 papers receiving 1.5k citations

Peers

Countries citing papers authored by Meilan Liu

Since Specialization

Citations

This map shows the geographic impact of Meilan Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meilan Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meilan Liu more than expected).

Fields of papers citing papers by Meilan Liu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Meilan Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meilan Liu. The network helps show where Meilan Liu may publish in the future.

Co-authorship network of co-authors of Meilan Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Meilan Liu. A scholar is included among the top collaborators of Meilan Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Meilan Liu. Meilan Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Mediating Effect of Coping Style Between Risk Perception of Complications and Self-Management in Patients with Type 2 Diabetes Mellitus 2024 ·Diabetes Metabolic Syndrome and Obesity ·Xiong Chen, Yaru Wang, Xiang Xie, (unknown), Meilan Liu, Xiaofang Zou	0
2	Bcl-xL Inhibition Radiosensitizes PIK3CA/PTEN Wild-type Triple-negative Breast Cancers with Low Mcl-1 Expression 2022 ·Cancer Research Communications ·(unknown), Benjamin C. Chandler, Anna R. Michmerhuizen, (unknown), (unknown), Kari Wilder-Romans, Meilan Liu, (unknown), (unknown), (unknown), (unknown), Lori J. Pierce, James M. Rae, Corey Speers	7
3	Estrogen receptor inhibition mediates radiosensitization of ER-positive breast cancer models 2022 ·npj Breast Cancer ·Anna R. Michmerhuizen, (unknown), (unknown), (unknown), Rachel Schwartz, Kari Wilder-Romans, Meilan Liu, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Bryan L. Wharram, Daniel F. Hayes, James M. Rae, Lori J. Pierce, Corey Speers	14
4	The role of salicylic acid in plant flower development 2022 ·SHILAP Revista de lepidopterología ·Ying Luo, Meilan Liu, Jie Cao, Fuliang Cao, Lin Zhang	13
5	Association of thyroid peroxidase antibodies with the rate of first-trimester miscarriage in euthyroid women with unexplained recurrent spontaneous abortion 2022 ·Frontiers in Endocrinology ·Meilan Liu, Dongyan Wang, Liqiong Zhu, (unknown), Xiaohui Ji, (unknown), Yuan Gao, Jianping Zhang, Yukun Liu, Rui Zhang, (unknown)	8
6	RB expression confers sensitivity to CDK4/6 inhibitor–mediated radiosensitization across breast cancer subtypes 2021 ·JCI Insight ·(unknown), (unknown), Anna R. Michmerhuizen, (unknown), Kari Wilder-Romans, Benjamin C. Chandler, Meilan Liu, (unknown), (unknown), (unknown), Erin F. Cobain, Theodore S. Lawrence, Lori J. Pierce, James M. Rae, Corey Speers	21
7	Short-term CDK4/6 Inhibition Radiosensitizes Estrogen Receptor–Positive Breast Cancers 2020 ·Clinical Cancer Research ·(unknown), (unknown), Benjamin C. Chandler, Anna R. Michmerhuizen, (unknown), (unknown), Kari Wilder-Romans, Meilan Liu, Christina L. Gersch, José M. Larios, Lori J. Pierce, James M. Rae, Corey Speers	35
8	PARP1 Inhibition Radiosensitizes Models of Inflammatory Breast Cancer to Ionizing Radiation 2019 ·Molecular Cancer Therapeutics ·Anna R. Michmerhuizen, (unknown), (unknown), Benjamin C. Chandler, Kari Wilder-Romans, Meleah Cameron, Eric Olsen, Dafydd G. Thomas, (unknown), (unknown), (unknown), Meilan Liu, Shyam Nyati, Lori J. Pierce, Reshma Jagsi, Corey Speers	41
9	ENERGY MEASURES ACROSS HOCKEY HELMET IMPACT LOCATIONS 2019 ·ISBS Proceedings Archive ·(unknown), (unknown), (unknown), Meilan Liu, (unknown)	1
10	NOD1 modulates decidual stromal cell function to maintain pregnancy in the early trimester 2019 ·Cell Biochemistry and Function ·Yuanyuan Zhang, Yuhui Zhang, (unknown), (unknown), Chunmei Li, (unknown), (unknown), Yan Song, Meilan Liu, Zhenhua Wang, (unknown), Jianping Zhang	13
11	Development and Validation of a Novel Radiosensitivity Signature in Human Breast Cancer 2015 ·Clinical Cancer Research ·Corey Speers, Shuang Zhao, Meilan Liu, Harry Bartelink, Lori J. Pierce, Felix Y. Feng	114
12	Effectiveness and potential mechanisms of intralipid in treating unexplained recurrent spontaneous abortion 2015 ·Archives of Gynecology and Obstetrics ·Lili Meng, Jizong Lin, Libin Chen, Zhenhua Wang, Meilan Liu, Yukun Liu, Xin Chen, Liqiong Zhu, Hui Chen, Jianping Zhang	50
13	Development and Validation of a Novel Platform-Independent Metastasis Signature in Human Breast Cancer 2015 ·PLoS ONE ·Shuang G. Zhao, Mark Shilkrut, Corey Speers, Meilan Liu, Kari Wilder-Romans, Theodore S. Lawrence, Lori J. Pierce, Felix Y. Feng	10
14	The lncRNA PCAT29 Inhibits Oncogenic Phenotypes in Prostate Cancer 2014 ·Molecular Cancer Research ·Rohit Malik, Lalit R. Patel, John R. Prensner, Yang Shi, Matthew K. Iyer, (unknown), (unknown), Yashar S. Niknafs, Anirban Sahu, Sumin Han, Teng Ma, Meilan Liu, Irfan A. Asangani, Xiaojun Jing, Xuhong Cao, Saravana M. Dhanasekaran, Dan R. Robinson, Felix Y. Feng, Arul M. Chinnaiyan	112
15	Targeted radiosensitization with PARP1 inhibition: optimization of therapy and identification of biomarkers of response in breast cancer 2014 ·Breast Cancer Research and Treatment ·Felix Y. Feng, Corey Speers, Meilan Liu, Will Jackson, Dominic H. Moon, Jacob Rinkinen, Kari Wilder-Romans, Reshma Jagsi, Lori J. Pierce	33
16	A Novel Small-Molecule Inhibitor of Mcl-1 Blocks Pancreatic Cancer Growth In Vitro and In Vivo 2013 ·Molecular Cancer Therapeutics ·Fardokht A. Abulwerdi, Chenzhong Liao, Meilan Liu, Asfar S. Azmi, Amro Aboukameel, Ahmed S.A. Mady, Thippeswamy Gulappa, Tomasz Cierpicki, Scott R. Owens, Tao Zhang, Duxin Sun, Jeanne A. Stuckey, Ramzi M. Mohammad, Zaneta Nikolovska‐Coleska	158
17	PARP-1 Inhibition as a Targeted Strategy to Treat Ewing's Sarcoma 2012 ·Cancer Research ·J. Chad Brenner, Felix Y. Feng, Sumin Han, Sonam Patel, (unknown), (unknown), Meilan Liu, Robert J. Lonigro, John R. Prensner, Scott A. Tomlins, Arul M. Chinnaiyan	206
18	Therapeutic Potential and Molecular Mechanism of a Novel, Potent, Nonpeptide, Smac Mimetic SM-164 in Combination with TRAIL for Cancer Treatment 2011 ·Molecular Cancer Therapeutics ·Jianfeng Lü, Donna McEachern, Haiying Sun, Longchuan Bai, Yuefeng Peng, Su Qiu, Rebecca S. Miller, Jinhui Liao, Yi Han, Meilan Liu, Anita C. Bellail, Chunhai Hao, Shi-Yong Sun, Adrian T. Ting, Shaomeng Wang	51
19	Natural BH3 mimetic (-)-gossypol chemosensitizes human prostate cancer via Bcl-xL inhibition accompanied by increase of Puma and Noxa 2008 ·Molecular Cancer Therapeutics ·Yang Meng, Wenhua Tang, Yao Dai, Xiaoqing Wu, Meilan Liu, Qing Ji, Min Ji, Kenneth J. Pienta, Theodore S. Lawrence, Liang Xu	167
20	Reactivation of p53 by a specific MDM2 antagonist (MI-43) leads to p21-mediated cell cycle arrest and selective cell death in colon cancer 2008 ·Molecular Cancer Therapeutics ·Sanjeev Shangary, Ke Ding, Su Qiu, Zaneta Nikolovska‐Coleska, Joshua A. Bauer, Meilan Liu, Guoping Wang, Yipin Lu, Donna McEachern, Denzil Bernard, Carol R. Bradford, Thomas E. Carey, Shaomeng Wang	75

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact